PharmaEssentia USA Appoints Jeffrey Williams as Independent Director

PharmaEssentia Corporation has appointed Jeffrey R. Williams as an Independent Director of PharmaEssentia USA. Williams, who has extensive experience in global finance and governance and has served as an Independent Director of PharmaEssentia Corporation in Taiwan since May 2024, will support the company’s ongoing international expansion. He also holds directorships at UBS SDIC Fund Management Company, UBS Asset Management (China), and Koo Foundation Cancer Center Hospital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PharmaEssentia Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20251224903318) on December 24, 2025, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.